Prasugrel versus clopidogrel in patients with acute coronary syndromes.: Results of the TRITON-TIMI 38 trial

被引：0
|
作者：
Preohrazhensky, D. V.
机构：
来源：
KARDIOLOGIYA | 2008年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 73
页数：2
相关论文
共 50 条
  • [41] Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
    Roe, Matthew T.
    Armstrong, Paul W.
    Fox, Keith A. A.
    White, Harvey D.
    Prabhakaran, Dorairaj
    Goodman, Shaun G.
    Cornel, Jan H.
    Bhatt, Deepak L.
    Clemmensen, Peter
    Martinez, Felipe
    Ardissino, Diego
    Nicolau, Jose C.
    Boden, William E.
    Gurbel, Paul A.
    Ruzyllo, Witold
    Dalby, Anthony J.
    McGuire, Darren K.
    Leiva-Pons, Jose L.
    Parkhomenko, Alexander
    Gottlieb, Shmuel
    Topacio, Gracita O.
    Hamm, Christian
    Pavlides, Gregory
    Goudev, Assen R.
    Oto, Ali
    Tseng, Chuen-Den
    Merkely, Bela
    Gasparovic, Vladimir
    Corbalan, Ramon
    Cinteza, Mircea
    McLendon, R. Craig
    Winters, Kenneth J.
    Brown, Eileen B.
    Lokhnygina, Yuliya
    Aylward, Philip E.
    Huber, Kurt
    Hochman, Judith S.
    Ohman, E. Magnus
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14): : 1297 - 1309
  • [42] Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention A TRITON-TIMI 38 Subgroup Analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38)
    Udell, Jacob A.
    Braunwald, Eugene
    Antman, Elliot M.
    Murphy, Sabina A.
    Montalescot, Gilles
    Wiviott, Stephen D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (06) : 604 - 612
  • [43] The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention A TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) Analysis
    O'Donoghue, Michelle
    Antman, Elliott M.
    Braunwald, Eugene
    Murphy, Sabina A.
    Steg, P. Gabriel
    Finkelstein, Ariel
    Penny, William F.
    Fridrich, Viliam
    McCabe, Carolyn H.
    Sabatine, Marc S.
    Wiviott, Stephen D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (08) : 678 - 685
  • [44] Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data
    Sorich, M. J.
    Vitry, A.
    Ward, M. B.
    Horowitz, J. D.
    Mckinnon, R. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (08) : 1678 - 1684
  • [45] Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy
    Riesmeyer, Jeffrey S.
    Salazar, Daniel E.
    Weerakkody, Govinda J.
    Ni, Lan
    Wrishko, Rebecca E.
    Ernest, C. Steven, II
    Luo, Junxiang
    Li, Ying G.
    Small, David S.
    Rohatagi, Shashank
    Macias, William L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (06): : 789 - 797
  • [46] Will prasugrel supersede clopidogrel for acute coronary syndromes?
    Hankey, Graeme J.
    Eikelboorn, John W.
    Langton, Paul E.
    MEDICAL JOURNAL OF AUSTRALIA, 2008, 188 (07) : 381 - 382
  • [47] Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
    Wiviott, Stephen D.
    Braunwald, Eugene
    McCabe, Carolyn H.
    Horvath, Ivan
    Keltai, Matyas
    Herrman, Jean-Paul R.
    Van de Werf, Frans
    Downey, William E.
    Scirica, Benjamin M.
    Murphy, Sabina A.
    Antman, Elliott M.
    LANCET, 2008, 371 (9621): : 1353 - 1363
  • [48] Utilization of Intensive Lipid-Lowering Therapy After an Acute Coronary Syndrome: Insights From the Triton-TIMI 38 Trial
    Steen, Dylan L.
    Umez-Eronini, Amarachi A.
    Hoffman, Elaine B.
    Antman, Elliott M.
    Wiviott, Stephen D.
    CIRCULATION, 2013, 128 (22)
  • [49] An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrel
    Wilcox, Robert
    Iqbal, Kamran
    Costigan, Timothy M.
    Lopez-Sendon, Jose
    Ramos, Yvonne
    Widimsky, Petr
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (11) : 2193 - 2205
  • [50] Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis
    Mega, Jessica L.
    Close, Sandra L.
    Wiviott, Stephen D.
    Shen, Lei
    Walker, Joseph R.
    Simon, Tabassome
    Antman, Elliott M.
    Braunwald, Eugene
    Sabatine, Marc S.
    LANCET, 2010, 376 (9749): : 1312 - 1319
12345